$10.95
0.05[0.46%]
At close: Apr 19
$10.95
0[0.00%]
After Hours: 4:00PM EDT
Sotera Health
(NASDAQ:SHC)Sotera Health Stock (NASDAQ:SHC), Analyst Ratings, Price Targets, Predictions
Sotera Health Co has a consensus price target of $16.96, established from looking at the 41 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Citigroup, and Jefferies on April 10, 2024, April 3, 2024, and March 25, 2024. With an average price target of $15.17 between Barclays, Citigroup, and Jefferies, there's an implied 38.51% upside for Sotera Health Co from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Citigroup
Jefferies
RBC Capital
Keybanc
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Sotera Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | SHC | Buy Now | Sotera Health | $10.95 | 27.85% | Barclays | Luke Sergott | $19 → $14 | Maintains | Overweight | Get Alert |
| 04/03/2024 | SHC | Buy Now | Sotera Health | $10.95 | 46.12% | Citigroup | Patrick Donnelly | $18 → $16 | Upgrade | Neutral → Buy | Get Alert |
| 03/25/2024 | SHC | Buy Now | Sotera Health | $10.95 | 41.55% | Jefferies | David Windley | $15 → $15.5 | Upgrade | Hold → Buy | Get Alert |
| 03/11/2024 | SHC | Buy Now | Sotera Health | $10.95 | 82.65% | RBC Capital | Sean Dodge | → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2024 | SHC | Buy Now | Sotera Health | $10.95 | 82.65% | RBC Capital | Sean Dodge | → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | SHC | Buy Now | Sotera Health | $10.95 | 73.52% | Barclays | Luke Sergott | $17 → $19 | Maintains | Overweight | Get Alert |
| 02/06/2024 | SHC | Buy Now | Sotera Health | $10.95 | — | Keybanc | Brett Fishbin | — | Initiates | → Sector Weight | Get Alert |
| 01/25/2024 | SHC | Buy Now | Sotera Health | $10.95 | 55.25% | Barclays | Luke Sergott | $15 → $17 | Maintains | Overweight | Get Alert |
| 11/02/2023 | SHC | Buy Now | Sotera Health | $10.95 | 82.65% | RBC Capital | Sean Dodge | $22 → $20 | Maintains | Outperform | Get Alert |
| 11/02/2023 | SHC | Buy Now | Sotera Health | $10.95 | 36.99% | Barclays | Luke Sergott | $20 → $15 | Maintains | Overweight | Get Alert |
| 08/04/2023 | SHC | Buy Now | Sotera Health | $10.95 | 100.91% | RBC Capital | Sean Dodge | $18 → $22 | Maintains | Outperform | Get Alert |
| 08/04/2023 | SHC | Buy Now | Sotera Health | $10.95 | 110.05% | Keybanc | Matthew Mishan | $24 → $23 | Maintains | Overweight | Get Alert |
| 06/26/2023 | SHC | Buy Now | Sotera Health | $10.95 | 119.18% | Keybanc | Matthew Mishan | → $24 | Upgrade | Sector Weight → Overweight | Get Alert |
| 06/22/2023 | SHC | Buy Now | Sotera Health | $10.95 | — | Keybanc | Matthew Mishan | — | Maintains | Sector Weight | Get Alert |
| 05/04/2023 | SHC | Buy Now | Sotera Health | $10.95 | 64.38% | RBC Capital | Sean Dodge | $19 → $18 | Maintains | Outperform | Get Alert |
| 05/04/2023 | SHC | Buy Now | Sotera Health | $10.95 | 82.65% | Barclays | Luke Sergott | $21 → $20 | Maintains | Overweight | Get Alert |
| 04/04/2023 | SHC | Buy Now | Sotera Health | $10.95 | 91.78% | Barclays | Luke Sergott | $22 → $21 | Maintains | Overweight | Get Alert |
| 03/01/2023 | SHC | Buy Now | Sotera Health | $10.95 | 73.52% | RBC Capital | Sean Dodge | $8 → $19 | Maintains | Outperform | Get Alert |
| 01/23/2023 | SHC | Buy Now | Sotera Health | $10.95 | 64.38% | JP Morgan | Tycho Peterson | $6 → $18 | Upgrade | Underweight → Neutral | Get Alert |
FAQ
What is the target price for Sotera Health (SHC)?
The latest price target for Sotera Health (NASDAQ: SHC) was reported by Barclays on April 10, 2024. The analyst firm set a price target for $14.00 expecting SHC to rise to within 12 months (a possible 27.85% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sotera Health (SHC)?
The latest analyst rating for Sotera Health (NASDAQ: SHC) was provided by Barclays, and Sotera Health maintained their overweight rating.
When was the last upgrade for Sotera Health (SHC)?
The last upgrade for Sotera Health Co happened on April 3, 2024 when Citigroup raised their price target to $16. Citigroup previously had a neutral for Sotera Health Co.
When was the last downgrade for Sotera Health (SHC)?
The last downgrade for Sotera Health Co happened on November 16, 2022 when Barclays changed their price target from $7 to $6 for Sotera Health Co.
When is the next analyst rating going to be posted or updated for Sotera Health (SHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sotera Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sotera Health was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Sotera Health (SHC) correct?
While ratings are subjective and will change, the latest Sotera Health (SHC) rating was a maintained with a price target of $19.00 to $14.00. The current price Sotera Health (SHC) is trading at is $10.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.